HEMATOLOGIC MALIGNANCIES
Clinical trials for HEMATOLOGIC MALIGNANCIES explained in plain language.
Never miss a new study
Get alerted when new HEMATOLOGIC MALIGNANCIES trials appear
Sign up with your email to follow new studies for HEMATOLOGIC MALIGNANCIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for tough blood cancers? early trial launches
Disease control Not yet recruitingThis early-phase study tests a new drug, BL-M24D1, in about 33 adults with multiple myeloma or other blood cancers that came back or didn't respond to standard treatments. The main goals are to check safety, find the right dose, and see if the drug shows any signs of working. Par…
Matched conditions: HEMATOLOGIC MALIGNANCIES
Phase: PHASE1 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
New cord blood transplant regimen aims to save elderly blood cancer patients
Disease control Not yet recruitingThis study tests a new combination of chemotherapy drugs before a cord blood transplant in 44 patients aged 60-69 with blood cancers. The goal is to see if this approach lowers the risk of death from transplant complications within 180 days. Participants receive the transplant an…
Matched conditions: HEMATOLOGIC MALIGNANCIES
Phase: PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
New hope for tough blood cancers? donor immune cells enter early trial
Disease control Not yet recruitingThis early study tests whether specially engineered immune cells from a donor (called CAR-T cells) are safe for people with B-cell blood cancers that have not responded to standard treatment or have returned. The trial will enroll 12 adults and aims to find the right dose while w…
Matched conditions: HEMATOLOGIC MALIGNANCIES
Phase: PHASE1 • Sponsor: YANRU WANG • Aim: Disease control
Last updated May 07, 2026 18:38 UTC